CAS 30516-87-1 Zidovudine API Active Pharmaceutical Ingredient Azidothymidine Reverse Transcriptase Inhibitor

Basic Information
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Drum/Bag
Delivery Time: Negotiation
Payment Terms: L/C, D/A, D/P, T/T
Supply Ability: Negotiation
Name: Zidovudine Synonyms: 3'-Deoxy-3'-azidothymi;1-[4-azido-5-(hydroxymethyl)-2-tetrahydrofuranyl]-5-methylpyrimidine-2,4-dione;1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione
Cas No: 30516-87-1 Ec No: 623-849-4
Molecular Formula: C10H13N5O5 Molecular Weight: 283.24
Melting Point: 113-115 °C Boiling Point: 410.43°C
Density: 1.3382
High Light:

CAS no 30516-87-1


30516-87-1 Zidovudine api


CAS number 30516-87-1

Zidovudine;CAS 30516-87-1;API;



Name Zidovudine
Synonyms 3'-Deoxy-3'-azidothymi;1-[4-azido-5-(hydroxymethyl)-2-tetrahydrofuranyl]-5-methylpyrimidine-2,4-dione;1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione
Molecular Formula C10H13N5O5
Molecular Weight 283.24
CAS Registry Number 30516-87-1
EINECS Number 623-849-4
Melting point 113-115 °C
density 1.3382
Boiling point 410.43°C


Product Description:


Zidovudine, also known as azidothymidine (AZT), is an antiviral agent acting via reverse transcnptase inhibition. It was first launched in the U.K. and subsequently introduced in over a dozen countries for the management of severe manifestations of HIV infection. In patients with AIDS and ARC, zidovudine reduces the risk of opportunistic infections and prolongs survival time. In symptom-free patients it shows promise in halting further immunological deterioration.


Product Use:


Zidovudine is an antiretroviral drug that is clinically active against HIV-1 and is intended to treat HIV-infected patients. Zidovudine is an analog of thymidine that inhibits replication of the AIDS virus. It also turned into mono-, di-, and triphosphates by the same cellular enzymes that catalyze phosphorylation of thymidine and thymidine nucleosides. Zidovudine-triphosphate is then included in the terminal fragment of the growing chain of viral DNA by viral reverse transcriptase, thus causing the viral DNA chain to break apart in cells infected with the virus.
Zidovudine has been authorized for treating patients with AIDS. It significantly prolongs the life of the patient, although it has a number of toxic effects. Synonyms of this drug are azidothymidine and retrovir.



CAS 30516-87-1 Zidovudine API Active Pharmaceutical Ingredient Azidothymidine Reverse Transcriptase Inhibitor 0


Product Catalogue:




Number Cas Name
1 62-46-4 Alpha Lipoic Acid
2 303-98-0 Coenzyme Q10
3 6020-87-7 Creatine Monohydrate
4 110-17-8 Fumaric Acid
5 3416-24-8 Glucosamine
6 87-89-8 Inositol
7 73-22-3 L-Tryptophan
8 56-87-1 L-Lysine
9 24634-61-5 Potassium Sorbate
10 56038-13-2 Sucralose
11 107-35-7 Taurine
12 128-13-2 Ursodeoxycholic Acid/ UDCA
13 59-43-8 Vitamin B1
14 83-88-5 Vitamin B2
15 8059-24-310 Vitamin B6
16 68-19-9 Vitamin B12
17 50-81-7 Vitamin C
18 1406-18-4 Vitamin E
19 11138-66-2 Xanthan Gum


About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.

Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486